Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: A systematic review

European Neuropsychopharmacology

Volumn 24, Issue 9, 2014, Pages 1425-1443

  Gobbo, Maria Angela ^a   Louzã, Mario R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atomoxetine; Attention deficit hyperactivity disorder; Driving; Psychostimulants; Treatment

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; LISDEXAMFETAMINE; METHYLPHENIDATE; PLACEBO;

ATTENTION DEFICIT DISORDER; CAR; CAR DRIVER; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; DRIVING ABILITY; DRUG EFFECT; DRUG EFFICACY; EMBASE; HIGH RISK BEHAVIOR; HUMAN; MEDICATION COMPLIANCE; MEDLINE; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SIMULATOR; SYSTEMATIC REVIEW; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAR DRIVING; COMPLICATION; PSYCHOMOTOR DISORDERS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOMOBILE DRIVING; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; PSYCHOMOTOR DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907597128     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.06.006     Document Type: Review

References (57)

1. Barkley R.A. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment 2005, Guilford, New York. 3rd ed.
2. Barkley R.A. Driving risks in adults with ADHD: yet more evidence and a personal story. ADHD Rep. 2006, 14:1-9.
3. Barkley R.A., Anderson D.L., Kruesi M. A pilot study of atomoxetine on driving performance in adults with Attention Deficit Hyperactivity Disorder (ADHD). J. Atten. Disord. 2007, 10:306-316.
4. Barkley R.A., Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J. Saf. Res. 2007, 38:113-128.
5. Barkley R.A., Murphy K., Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996, 98:1089-1095.
6. Barkley R.A., Murphy K.R., Dupaul G.J., Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcome, and the role of executive functioning. J. Int. Neuropsychol. Soc. 2002, 8:655-672.
7. Barkley R.A., Murphy K.R., O'Connell T., Connor D.F. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. J. Saf. Res. 2005, 36:121-131.
8. Barry R.J., Clarke A.R., Mccarthy R., Selikowitz M., Brown C.R., Heaven P.C. Event-related potentials in adults with Attention-Deficit/Hyperactivity Disorder: an investigation using an inter-modal auditory/visual oddball task. Int. J. Psychophysiol. 2009, 71:124-131.
9. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366:237-248.
10. Biederman J., Fried R., Hammerness P., Surman C., Mehler B., Petty C.R., Faraone S.V., Miller C., Bourgeois M., Meller B., Godfrey K.M., Reimer B. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J. Psychiatr. Res. 2012, 46:484-491.
11. Biederman J., Fried R., Hammerness P., Surman C., Mehler B., Petty C.R., Faraone S.V., Miller C., Bourgeois M., Meller B., Godfrey K.M., Baer L., Reimer B. The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire. J. Adolesc Health. 2012, 51(6):601-607.
12. Biederman J., Fried R., Monuteaux M.C., Reimer B., Coughlin J.F., Surman C.B., Aleardi M., Dougherty M., Schoenfeld S., Spencer T.J., Faraone S.V. A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study. Ann. Gen. Psychiatr. 2007, 6:4.
13. Bina M., Graziano F., Bonino S. Risky driving and lifestyles in adolescence. Accid. Anal. Prev. 2006, 38:472-481.
14. Bjørkli, C., Flø, M., Jenssen, G.D., Ryum, T., Zeiner, P., 2005. Assessment of Fitness-to-drive Amongst Patients with Learning Difficulties (accessed 15.12.12). http://www.sintef.no/upload/A05027_D-R1.8-ny%20version-092004.pdf.
15. Brooks J.O., Goodenough R.R., Crisler M.C., Klein N.D., Alley R.L., Koon B.L., Logan W.C., Ogle J.H., Tyrrell R.A., Wills R.F. Simulator sickness during driving simulation studies. Accid. Anal. Prev. 2010, 42:788-796.
16. Classen S., Bewernitz M., Shechtman O. Driving simulator sickness: an evidence-based review of the literature. Am. J. Occup. Ther. 2011, 65:179-188.
17. Classen S., Wang Y., Crizzle A.M., Winter S.M., Lanford D.M. Gender differences among older drivers in a comprehensive driving evaluation. Accid. Anal. Prev. 2013, 61:146-152.
18. Cox D.J., Davis M., Mikami A.Y., Singh H., Merkel R.L., Burket R. Long-acting methylphenidate reduces collision rates of young adult ADHD drivers. J. Clin. Psychopharmacol. 2012, 32:225-230.
19. Cox D.J., Humphrey J.W., Merkel R.L., Penberthy J.K., Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. J. Am. Board Fam. Pract. 2004, 17:235-239.
20. Cox D.J., Madaan V., Cox B.S. Adult attention deficit/hyperactivity disorder and driving: why and how to manage it. Curr. Psychiatry Rep. 2011, 13:345-350.
21. Cox D.J., Merkel R.L., Kovatchev B., Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J. Nerv. Ment. Dis. 2000, 188:230-234.
22. Cox D.J., Merkel R.L., Moore M., Thorndike F., Muller C., Kovatchev B. Relative benefits of stimulant therapy with OROS methylphenidate vs mixed amphetamine salts extended-release in improving the driving performance of adolescent drivers with ADHD. Pediatrics 2006, 118:e704-e710.
23. Cox D.J., Merkel R.L., Penberthy J.K., Kovatchev B., Hankin C.S. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention deficit/hyperactivity disorder: a pilot study. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:269-275.
24. Cox D.J., Moore M., Burket R., Merkel R.L., Mikami A.Y., Kovatchev B. Rebound effects with long acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention deficit/hyperactivity disorder. J. Child. Adolesc. Psychopharmacol. 2008, 18:1-10.
25. Durlak J.A. How to select, calculate, and interpret effect sizes. J. Pediatr. Psychol. 2009, 34(9):917-928.
26. Elbourne D.R., Altman D.G., Higgins J.P., Curtin F., Worthington H.V., Vail A. Meta-analyses involving cross-over trials: methodological issues. Int. J. Epidemiol. 2002, 31(1):140-149.
27. Elliott M.R., Shope J.T., Raghunathan T.E., Waller P.F. Gender differences among young drivers in the association between high-risk driving and substance use/environmental influences. J. Stud. Alcohol. 2006, 67:252-260.
28. Faraone S.V., Glatt S.J. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J. Clin. Psychiatry 2010, 71:754-763.
29. Festinger D.S., Marlowe D.B., Dugosh K.L., Croft J.R., Arabia P.L. Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug Alcohol Depend. 2008, 96:128-135.
30. Fischer M., Barkley R.A., Smallish L., Fletcher K. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accid. Anal. Prev. 2007, 39:94-105.
31. Graziano P.A., Reid A., Slavec J., Paneto A., McNamara J.P., Geffken G.R. ADHD symptomatology and risky health, driving, and financial behaviors in college: the mediating role of sensation seeking and effortful control. J. Atten. Disord. 2014, (Epub ahead of print).
32. Huang-Pollock C.L., Karalunas S.L., Tam H., Moore A.N. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J. Abnorm. Psychol. 2012, 121:360-371.
33. Jerome L., Sega,l A., Habinski L. What we know about ADHD and driving risk: a literature review, meta-analysis and critique. J. Can. Acad. Child. Adolesc. Psychiatry 2006, 15:105-125.
34. Kay G.G., Michaels M.A., Pakull B. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. J. Atten. Disord. 2009, 12:316-329.
35. Kooij S.J., Bejerot S., Blackwell A., Caci H., Casas-Brugué M., Carpentier P.J., Edvinsson D., Fayyad J., Foeken K., Fitzgerald M., Gaillac V., Ginsberg Y., Henry C., Krause J., Lensing M.B., Manor I., Niederhofer H., Nunes-Filipe C., Ohlmeier M.D., Oswald P., Pallanti S., Pehlivanidis A., Ramos-Quiroga J.A., Rastam M., Ryffel-Rawak D., Stes S., Asherson P. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010, 10:67.
36. Largent E.A., Grady C., Miller F.G., Wertheimer A. Money, coercion, and undue inducement: attitudes about payments to research participants. IRB 2012, 34:1-8.
37. Ludolph A.G., Kölch M., Plener P.L., Schulze U.M., Spröber N., Fegert J.M.Z. Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD. Z. Kinder Jugendpsychiatrie Psychother. 2009, 37:405-411.
38. Merkel R.L., Nichols J.Q., Fellers J.C., Hidalgo P., Martinez L.A., Putziger I., Burket R.C., Cox D.J. Comparison of on-road driving between young adults with and without ADHD. J. Atten. Disord. 2013, (Epub ahead of print).
39. Mikami A.Y., Cox D.J., Davis M.T., Wilson H.K., Merkel R.L., Burket R. Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder. J. Clin. Psychol. Med. Settings 2009, 16:233-242.
40. MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group Multimodal Treatment Study of Children with ADHD. Arch. Gen. Psychiatry 1999, 56:1073-1086.
41. Narad M., Garner A.A., Brassell A.A., Saxby D., Antonini T.N., O'Brien K.M., Tamm L., Matthews G., Epstein J.N. Impact of distraction on the driving performance of adolescents with and without attention-deficit/hyperactivity disorder. J. Am. Med. Assoc. Pediatr. 2013, 167(10):933-938.
42. Pliszka S. AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46:894-921.
43. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164:942-948.
44. Polanczyk G., Rohde L.A. Epidemiology of attention deficit/hyperactivity disorder across the lifespan. Curr. Opin. Psychiatry 2007, 20:386-392.
45. Rappley M.D. Clinical practice. Attention deficit-hyperactivity disorder. N. Engl. J. Med. 2005, 352:165-173.
46. Rasmussen P., Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J. Am. Acad. Child. Adolesc. Psychiatry 2000, 39:1424-1431.
47. Reimer B., D'Ambrosio L.A., Coughlin J.F., Fried R., Biederman J. Task-induced fatigue and collisions in adult drivers with attention deficit hyperactivity disorder. Traffic Inj. Prev. 2007, 8:290-299.
48. Seixas M., Weiss M., Müller U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J. Psychopharmacol. 2012, 26:753-765.
49. Sobanski E., Sabljic D., Alm B., Dittmann R.W., Wehmeier P.M., Skopp G., Strohbeck-Kühner P. Driving performance in adults with ADHD: results from a randomized, waiting list controlled trial with atomoxetine. Eur. Psychiatry 2013, 28:379-385.
50. Sobanski E., Sabljic D., Alm B., Skopp G., Kettler N., Mattern R., Strohbeck-Kühner P. Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD). J. Neural Transm. 2008, 115:347-356.
51. Vaa T. ADHD and relative risk of accidents in road traffic: a meta-analysis. Accid. Anal. Prev. 2014, 62:415-425.
52. Vavrik J. Personality and risk-taking: a brief report on adolescent male drivers. J. Adolesc. 1997, 20:461-465.
53. Verster J.C., Roth T. Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int. J. Gen. Med. 2011, 4:359-371.
54. Verster J.C., Bekker E.M., de Roos M., Minova A., Eijken E.J., Kooij J.J., Buitelaar J.K., Kenemans J.L., Verbaten M.N., Olivier B., Volkerts E.R. Methylphenidate significantly improves driving performance of adults with attention deficit hyperactivity disorder: a randomized crossover trial. J. Psychopharmacol. 2008, 22:230-237.
55. Weiss G., Hechtman L., Perlman T., Hopkins J., Wener A. Hyperactives as young adults: a controlled prospective ten-year follow-up of 75 children. Arch. Gen. Psychiatry 1979, 36:675-681.
56. Wigal S.B. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 2009, 23:21-31.
57. Wilens T.E., Faraone S.V., Biederman J. Attention-deficit/hyperactivity disorder in adults. J. Am. Med. Assoc. 2004, 292:619-623.